JP Morgan Chase’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $787K | Hold |
|
|||||
|
2022
Q4 | $524K | Sell |
|
|||||
|
2022
Q3 | $947K | Sell |
|
|||||
|
2022
Q2 | $2.03M | Sell |
|
|||||
|
2022
Q1 | $1.97M | Sell |
|
|||||
|
2021
Q4 | $4.34M | Sell |
|
|||||
|
2021
Q3 | $8.77M | Buy |
|
|||||
|
2021
Q2 | $10.8M | Buy |
|
|||||
|
2021
Q1 | $14.5M | Buy |
|
|||||
|
2020
Q4 | $14.2M | Buy |
|
|||||
|
2020
Q3 | $5.11M | Buy |
|
|||||
|
2020
Q2 | $3.77M | Buy |
|
|||||
|
2020
Q1 | $1.75M | Buy |
|
|||||
|
2019
Q4 | $2.96M | Buy |
|
|||||
|
2019
Q3 | $3.04M | Buy |
|
|||||
|
2019
Q2 | $2.79M | Sell |
|
|||||
|
2019
Q1 | $3.46M | Buy |
|